Key result
Transaxillary transcatheter aortic valve replacement using an Edwards SAPIEN 3 device was described in a 77-year-old male with a complex surgical history including a left subclavian artery stent.
Why the study?
For TAVR patients with inadequate iliofemoral access, alternative routes carry high vascular injury risk and often require open surgical exposure under general anesthesia.
Case Report (n=1)
Transaxillary TAVR using a balloon-expandable device is feasible even in patients with complex vascular and device histories, including ipsilateral subclavian stents and pacemakers.
Transcatheter aortic valve replacement (TAVR) has become the procedure of choice for patients deemed high-risk or inoperable for surgical aortic valve replacement. For patients with inadequate iliofemoral access, the risk of vascular injury is extremely high and alternative techniques have been utilized and include the transapical, transaortic and transsubclavian or transaxillary (TAx) routes. Alternative approaches often require open surgical exposure under general anesthesia. Herein, we describe a unique TAx TAVR with a balloon-expandable Edwards SAPIEN 3 device in a 77 year-old male patient with the history of coronary artery and ilio-femoral bypass surgery, permanent pacemaker implantation at the left pectoral fossa and left subclavian artery stent.
No takes yet. Share an insight, caveat, or question.
Aslan et al. (2020) conducted a case report in Aortic valve disease requiring TAVR (n=1). Transaxillary transcatheter aortic valve replacement (TAx TAVR) was evaluated. Transaxillary transcatheter aortic valve replacement using an Edwards SAPIEN 3 device was described in a 77-year-old male with a complex surgical history including a left subclavian artery stent.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: